Skip to content

FRailty Among Elderly Emergency Department Patients With Outcome Measures

FRailty Among Elderly Emergency Department Patients With Outcome Measures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03814161
Acronym
FREEDOM
Enrollment
211
Registered
2019-01-23
Start date
2019-01-20
Completion date
2023-12-01
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric, Frailty, Emergency Department

Brief summary

Our study aims to compare 4 clinical frailty scores, namely Clinical Frailty Scale (CFS), Edmonton Frail Scale (EFS), FRAIL 5-item scale (FRAIL) and SARC-F Sarcopenia Score (SARC-F), which can potentially be adopted for daily practice in the busy ED. It is timely as we projected that we will be seeing more elderly patients attending the ED for various medical and surgical conditions. Their attendance at the ED would be a good opportunity to screen for frailty among them, and to intervene to prevent adverse outcomes such as ED re-attendance or subsequent hospitalisation that might lead to poor functional outcomes and higher dependence on step-down care facilities.

Interventions

None listed

Sponsors

National University Hospital, Singapore
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Elderly patients aged 65 years and above attending ED irrespective of reason for attendance.

Exclusion criteria

* Haemodynamically unstable patients * Inability to obtain informed consent * Inability to obtain reliable information from patient or caregiver (e.g. deafness, blindness, language barriers) * Vulnerable populations (e.g. prisoners) * Patients who are planned for hospital admission from the ED

Design outcomes

Primary

MeasureTime frameDescription
1-month Adverse Event Occurrence (composite)At 1 month after index ED visitFalls, ED re-attendance, hospital/ nursing home admission, decline in Activities of Daily Living and/or all-cause mortality

Secondary

MeasureTime frameDescription
3-month Adverse Event Occurrence (composite)At 3 months after index ED visitFalls, ED re-attendance, hospital/ nursing home admission, decline in Activities of Daily Living and/or all-cause mortality

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026